Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-24T16:03:28.757Z Has data issue: false hasContentIssue false
  • English
  • Français

Melody® pulmonary valve implantation in two teenage patients with congenitally corrected transposition of the great arteries status after Senning atrial switch operation

Published online by Cambridge University Press:  17 October 2016

Rodrigo Rios ,
Susan R. Foerster  and
Todd M. Gudausky
Rodrigo Rios
Affiliation:
Division of Cardiology, Medical College of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, United States of America
Susan R. Foerster
Affiliation:
Division of Cardiology, Medical College of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, United States of America
Todd M. Gudausky*
Affiliation:
Division of Cardiology, Medical College of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, United States of America
*
Correspondence to: Todd Gudausky, MD, Division of Cardiology, Medical College of Wisconsin, Children’s Hospital of Wisconsin, P.O. Box 1997, MS 713, Milwaukee, WI 53201-1997, United States of America. Tel: 414-266-2380; Fax: 414-266-3261; E-mail: rrios@chw.org
Get access Rights & Permissions [Opens in a new window]

Abstract

The Melody® transcatheter pulmonary valve system was developed for placement within right ventricle-to-pulmonary artery conduits in patients with CHD for treatment of stenosis or regurgitation, providing an alternative to open-heart surgery. Abnormal systemic venous connections altering the catheter course to the right ventricle-to-pulmonary artery conduit may present a challenge to Melody® valve implantation. We present two such cases, in which the Melody® valve was successfully implanted in teenage patients with congenitally corrected transposition of the great arteries after Senning atrial switch operation. Despite the abnormal catheter course, the right ventricle-to-pulmonary artery was approachable via the right femoral vein allowing for deployment of the Melody® valve in the appropriate position. This suggests that systemic vein-to-left atrium baffles are not prohibitive of Melody® valve implantation. This is an important implication considering the substantial population of ageing patients with CHD who have undergone atrial switch. Melody® valve implantation can be considered as a viable option for treatment of these patients if they develop right ventricle-to-pulmonary artery conduit failure.

Keywords

CHDtranscatheter valve implantationpulmonary valve intervention
Type
Brief Report
Information
Cardiology in the Young , Volume 27 , Issue 3 , March 2017 , pp. 600 - 604
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Ansari, MM, Cardoso, R, Garcia, D, et al. Percutaneous pulmonary valve implantation: present status and evolving future. J Am Coll Cardiol 2015; 66: 2246–2255.Google Scholar
2. McElhinney, DB, Hennesen, JT. The Melody® valve and Ensemble® delivery system for transcatheter pulmonary valve replacement. Ann N Y Acad Sci 2013; 1291: 77–85.Google Scholar
3. Asnes, J, Hellenbrand, WE. Evaluation of the Melody transcatheter pulmonary valve and Ensemble delivery system for the treatment of dysfunctional right ventricle to pulmonary artery conduits. Expert Rev Med Devices 2015; 12: 653–665.Google Scholar
4. Boudjemline, Y, Malekzadeh-Milani, S, Patel, M, et al. Predictors and outcomes of right ventricular outflow tract conduit rupture during percutaneous pulmonary valve implantation: a multicentre study. EuroIntervention 2016; 11: 1053–1062.Google Scholar
5. Armstrong, AK, Balzer, DT, Cabalka, AK, et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv 2014; 7: 1254–1262.Google Scholar